359 related articles for article (PubMed ID: 25740198)
1. LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease.
Tyurina YY; Polimova AM; Maciel E; Tyurin VA; Kapralova VI; Winnica DE; Vikulina AS; Domingues MR; McCoy J; Sanders LH; Bayır H; Greenamyre JT; Kagan VE
Free Radic Res; 2015 May; 49(5):681-91. PubMed ID: 25740198
[TBL] [Abstract][Full Text] [Related]
2. LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.
Tyurina YY; Winnica DE; Kapralova VI; Kapralov AA; Tyurin VA; Kagan VE
Mol Nutr Food Res; 2013 Aug; 57(8):1410-22. PubMed ID: 23650208
[TBL] [Abstract][Full Text] [Related]
3. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
4. Oxidized phospholipids as biomarkers of tissue and cell damage with a focus on cardiolipin.
Samhan-Arias AK; Ji J; Demidova OM; Sparvero LJ; Feng W; Tyurin V; Tyurina YY; Epperly MW; Shvedova AA; Greenberger JS; Bayır H; Kagan VE; Amoscato AA
Biochim Biophys Acta; 2012 Oct; 1818(10):2413-23. PubMed ID: 22464971
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acids incorporation into cardiolipin in H9c2 cardiac myoblast.
Ting HC; Chao YJ; Hsu YH
J Nutr Biochem; 2015 Jul; 26(7):769-75. PubMed ID: 25866137
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson's disease- emphasizing the role of mitochondrial biogenesis.
Peshattiwar V; Muke S; Kaikini A; Bagle S; Dighe V; Sathaye S
Brain Res Bull; 2020 Jul; 160():150-161. PubMed ID: 32147532
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
Ebrahimi SS; Oryan S; Izadpanah E; Hassanzadeh K
Toxicol Lett; 2017 Jul; 276():108-114. PubMed ID: 28526446
[TBL] [Abstract][Full Text] [Related]
8. Daily chronomics of proteomic profile in aging and rotenone-induced Parkinson's disease model in male Wistar rat and its modulation by melatonin.
Jagota A; Mattam U
Biogerontology; 2017 Aug; 18(4):615-630. PubMed ID: 28577110
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
Rahimmi A; Khosrobakhsh F; Izadpanah E; Moloudi MR; Hassanzadeh K
Brain Res Bull; 2015 Apr; 113():34-40. PubMed ID: 25732239
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function.
Serrano-García N; Fernández-Valverde F; Luis-Garcia ER; Granados-Rojas L; Juárez-Zepeda TE; Orozco-Suárez SA; Pedraza-Chaverri J; Orozco-Ibarra M; Jiménez-Anguiano A
Neurochem Int; 2018 Dec; 121():26-37. PubMed ID: 30342962
[TBL] [Abstract][Full Text] [Related]
11. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.
Marella M; Seo BB; Nakamaru-Ogiso E; Greenamyre JT; Matsuno-Yagi A; Yagi T
PLoS One; 2008 Jan; 3(1):e1433. PubMed ID: 18197244
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
[TBL] [Abstract][Full Text] [Related]
14. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
De Miranda BR; Rocha EM; Bai Q; El Ayadi A; Hinkle D; Burton EA; Timothy Greenamyre J
Neurobiol Dis; 2018 Jul; 115():101-114. PubMed ID: 29649621
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.
Sanders LH; McCoy J; Hu X; Mastroberardino PG; Dickinson BC; Chang CJ; Chu CT; Van Houten B; Greenamyre JT
Neurobiol Dis; 2014 Oct; 70():214-23. PubMed ID: 24981012
[TBL] [Abstract][Full Text] [Related]
17. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
18. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome.
Sullivan EM; Pennington ER; Sparagna GC; Torres MJ; Neufer PD; Harris M; Washington J; Anderson EJ; Zeczycki TN; Brown DA; Shaikh SR
J Biol Chem; 2018 Jan; 293(2):466-483. PubMed ID: 29162722
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson's Disease.
Zaman V; Drasites KP; Myatich A; Shams R; Shields DC; Matzelle D; Haque A; Banik NL
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
